Document:

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS DOCUMENT NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER AND REASONABLY APPROVED BY THE COMPANY), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

 

 

 

REVOLUTIONS MEDICAL CORPORATION

 

FORM OF COMMON STOCK PURCHASE WARRANT

 

	Number of shares:  _____________	Holder:  ______________
	 	 
	Exercise Price per Share:  $_______	Warrant No. ______

 

Expiration Date: December 31, 2012

(or such later date as shall be determined

pursuant to the introductory paragraphs below)

 

FOR VALUE RECEIVED, Revolutions Medical
Corporation, a corporation incorporated under the laws of the State of Nevada (the “Company”), hereby certifies
that __________________, or his registered assigns (the “Warrant Holder”), is entitled, subject to the terms
set forth below, to purchase from the Company ___________________ (___________) shares (the “Warrant Shares”)
of common stock, $0.001 par value (the “Common Stock”), of the Company at an exercise price of ____________
and ___/100 United States Dollars (US$_________) per share (as adjusted from time to time as provided in Section 6, per Warrant
Share (the “Exercise Price”), at any time and from time to time from and after the date thereof and through
and including 5:00 p.m. New York City time on the Expiration Date.

 

The “Expiration Date” shall
mean the later of (i) December 31, 2012 or (ii) provided that the Company issues any Additional Warrants or there
exists any Extended Warrants, the earlier of (a) June 30, 2013 and (b) the latest expiration date of any Additional Warrant issued
or any Extended Warrant extended by the Company prior to December 31, 2012. The term “Additional Warrants” shall
mean warrants issued by the Company after the date hereof in connection with any investment by the Company which is made on substantially
similar terms as the investment made in connection with this transaction (taking into account the size and scope of such issuances
related to this transaction). The term “Extended Warrants” shall mean any warrants currently registered in the Company’s
Form S-1 Registration Statement filed with the United States Securities and Exchange Commission (the “Commission”)
on December 14, 2011 which such warrants expiration date is hereinafter extended later than December 31, 2012.

 

    	1

    	 

    
 

This Warrant is subject to the following terms and conditions:

 

1. Registration of Warrant.
The Company shall register this Warrant upon records to be maintained by the Company for that purpose (the “Warrant Register”),
in the name of the record Warrant Holder hereof from time to time. The Company may deem and treat the registered Warrant Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or nay distribution to the Warrant Holder,
and for all other purposes, and the Company shall not be affected by notice to the contrary.

 

2. Investment Representation.
The Warrant Holder by accepting this Warrant represents that the Warrant Holder is acquiring this Warrant for its own account or
the account of an affiliate for investment purposes and not with the view to any offering or distribution and that the Warrant
Holder will not sell or otherwise dispose of this Warrant or the underlying Warrant Shares in violation of applicable securities
laws. The Warrant Holder acknowledges that the certificates representing any Warrant Shares will bear a legend indicating that
they have not been registered under the United States Securities Act of 1933, as amended (the “1933 Act”) and
may not be sold by the Warrant Holder except pursuant to an effective registration statement or pursuant to an exemption from registration
requirements of the 1933 Act and in accordance with federal and state securities laws. If this Warrant was acquired by the Warrant
Holder pursuant to the exemption from the registration requirements of the 1933 Act afforded by Regulation S thereunder, the Warrant
Holder acknowledges and covenants that this Warrant may not be exercised by or on behalf of a Person during the one year distribution
compliance period (as defined in Regulation S) following the date hereof. “Person” means an individual, partnership,
firm, limited liability company, trust, joint venture, association, corporation, or any other legal entity.

 

3. Validity of Warrant
and Issue of Shares. The Company represents and warrants that this Warrant has been duly authorized and validly issued and
warrants and agrees that all of Common Stock that may be issued upon the exercise of the rights represented by this Warrant will,
when issued upon such exercise, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens
and charges with respect to the issue thereof. The Company further warrants and agrees that during the period within which the
rights represented by this Warrant may be exercised, the Company will at all times have authorized and reserved a sufficient number
of Common Stock to provide for the exercise of the rights represented by this Warrant.

 

    	2

    	 

    
 

4. Registration
of Transfers and Exchange of Warrants.

 

a. Subject to compliance
with the legend set forth on the face of this Warrant, the Company shall register the transfer of any portion of this Warrant in
the Warrant Register, upon surrender of this Warrant with the Form of Assignment attached hereto duly completed and signed, to
the Company at the office specified in or pursuant to Section 9. Upon any such registration or transfer, a new warrant to purchase
Common Stock, in substantially the form of this Warrant (any such new warrant, a “New Warrant”), evidencing
the portion of this Warrant so transferred shall be issued to the transferee and a New Warrant evidencing the remaining portion
of this Warrant not so transferred, if any, shall be issued to the transferring Warrant Holder. The acceptance of the New Warrant
by the transferee thereof shall be deemed the acceptance of such transferee of all of the rights and obligations of a Warrant Holder
of a Warrant.

 

b. This Warrant is exchangeable,
upon the surrender hereof by the Warrant Holder to the office of the Company specified in or pursuant to Section 9 for one or more
New Warrants, evidencing in the aggregate the right to purchase the number of Warrant Shares which may then be purchased hereunder.
Any such New Warrant will be dated the date of such exchange.

 

5. Exercise
of Warrants.

 

a. Exercise of this Warrant
shall be made upon surrender of this Warrant with the Form of Election to Purchase attached hereto duly completed and signed to
the Company, at its address set forth in Section 9. Payment upon exercise may be made at the written option of the Warrant Holder
either in (i) cash, wire transfer or by certified or official bank check payable to the order of the Company equal to the applicable
aggregate purchase price, (ii) by delivery of Warrant Shares issuable upon exercise of the Warrants in accordance with Section
(b) below or (iii) by a combination of any of the foregoing methods, for the number of Warrant Shares specified in such form (as
such exercise number shall be adjusted to reflect any adjustment in the total number of Warrant Shares issuable to the Warrant
Holder per the terms of this Warrant) and the Warrant Holder shall thereupon be entitled to receive the number of duly authorized,
validly issued, fully-paid and non-assessable Warrant Shares determined as provided herein. The Company shall promptly (but in
no event later than five (5) business days after the Date of Exercise as defined herein) issue or cause to be issued and cause
to be delivered to or upon the written order of the Warrant Holder and in such name or names as the Warrant Holder may designate
(subject to the restrictions on transfer described in the legend set forth on the face of this Warrant), a certificate for the
Warrant Shares issuable upon such exercise, with such restrictive legend as required by the 1933 Act, as applicable. Any person
so designated by the Warrant Holder to receive Warrant Shares shall be deemed to have become holder of record of such Warrant Shares
as of the Date of Exercise of this Warrant.

 

    	3

    	 

    
 

b. If the closing price
(as quoted by the OTC Markets or other principal trading market, if applicable) reported on the day immediately preceding the Date
of Exercise (the “Fair Market Value”) of one share of Common Stock is greater than the Exercise Price of one
Warrant Share (at the date of calculation as set forth below), in lieu of exercising this Warrant for cash, the Warrant Holder
may elect to receive shares equal to the number of shares of Common Stock computed using the following formula:

 

X=      Y (A-B)

A

 

Where X= the number of shares of
Common Stock to be issued to the Warrant Holder

 

Y= the number of shares of
Common Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the
Warrant being exercised (at the date of such calculation)

 

A= Fair Market Value

 

B= Exercise Price (as adjusted
to the date of such calculation)

 

For purposes of Rule 144
promulgated under the 1933 Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise
transaction in the manner described above shall be deemed to have been acquired by the Warrant Holder, and the holding period for
the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.

 

c. A “Date of
Exercise” means the date on which the Company shall have received (i) this Warrant (or any New Warrant, as applicable),
with the Form of Election to Purchase attached hereto (or attached to such New Warrant) appropriately completed and duly signed,
and (ii) payment of the Exercise Price for the number of Warrant Shares so indicated by the Warrant Holder to be purchased.

 

d. This Warrant shall
be exercisable at any time and from time to time for such number of Warrant Shares as is indicated in the attached Form of Election
To Purchase. If less than all of the Warrant Shares which may be purchased under this Warrant are exercised at any time, the Company
shall issue or cause to be issued, at its expense, a New Warrant evidencing the right to purchase the remaining number of Warrant
Shares for which no exercise has been evidenced by this Warrant.

 

6. Adjustment of Exercise
Price and Number of Shares. The character of the shares of stock or other securities at the time issuable upon exercise of
this Warrant and the Exercise Price therefor, are subject to adjustment upon the occurrence of the following events:

 

a. Adjustment for Stock
Splits, Stock Dividends, Recapitalizations, Etc. The Exercise Price of this Warrant and the number of shares of Common Stock
or other securities at the time issuable upon exercise of this Warrant shall be appropriately adjusted to reflect any stock dividend,
stock split, combination of shares, reclassification, recapitalization or other similar event affecting the number of outstanding
shares of stock or securities.

 

b. Adjustment for Reorganization,
Consolidation, Merger, Etc. In case of any consolidation or merger of the Company with or into any other corporation, entity
or person, or any other corporate reorganization, in which the Company shall not be the continuing or surviving entity of such
consolidation, merger or reorganization (any such transaction being hereinafter referred to as a “Reorganization”),
then, in each case, the holder of this Warrant, on exercise hereof at any time after the consummation or effective date of such
Reorganization (the “Effective Date”), shall receive, in lieu of the shares of stock or other securities at
any time issuable upon the exercise of the Warrant issuable on such exercise prior to the Effective Date, the stock and other securities
and property (including cash) to which such holder would have been entitled upon the Effective Date if such holder had exercised
this Warrant immediately prior thereto (all subject to further adjustment as provided in this Warrant).

 

    	4

    	 

    
 

c. Certificate as to Adjustments.
In case of any adjustment or readjustment in the price or kind of securities issuable on the exercise of this Warrant, the Company
will promptly give written notice thereof to the holder of this Warrant in the form of a certificate, certified and confirmed by
the Board of Directors of the Company, setting forth such adjustment or readjustment and showing in reasonable detail the facts
upon which such adjustment or readjustment is based.

 

7. Registration
Rights. If, after the date hereof, the Company shall prepare and file with the United States Securities and Exchange
Commission (the "Commission") a registration statement relating to an offering for its own account or the account of others
under the 1933 Act of any of its equity securities, other than on Form S-4 or Form S-8 (each as  promulgated under the 1933
Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of any
entity or business or equity securities issuable in connection with stock option or other employee benefit plans, then the
Company shall send to the Warrant Holder written notice of such determination and, unless the Warrant Holder objects to the
registration of the Warrant Shares or any part thereof in writing within ten (10) calendar days after receipt of such notice,
the Company shall include in such registration statement all of the Warrant Shares, subject to customary cutbacks applicable
to all holders of registration rights.   To the extent not all of the Warrant Shares may be included for registration in the
registration statement, as a result of the Commission’s application of Rule 415 under the 1933 Act, priority in such
registration statement will be given to the other Common Stock included therein in preference to the Warrant Shares except no
preference shall be given to shares held by affiliates.  The obligations of the Company under this Section may be waived by
the Warrant Holder.  Notwithstanding anything to the contrary herein, the registration rights granted to the Warrant Holder
shall not be applicable for such times as such Warrant Shares may be sold by the Holder thereof without restriction pursuant
to Rule 144 of the 1933 Act.

 

8. Fractional Shares.
The Company shall not be required to issue or cause to be issued fractional Warrant Shares on the exercise of this Warrant. The
number of full Warrant Shares that shall be issuable upon the exercise of this Warrant shall be computed on the basis of the aggregate
number of Warrants Shares purchasable on exercise of this Warrant so presented. If any fraction of a Warrant Share would, except
for the provisions of this Section 7, be issuable on the exercise of this Warrant, the Company shall, at its option, (i) pay an
amount in cash equal to the Exercise Price multiplied by such fraction or (ii) round the number of Warrant Shares issuable, up
to the next whole number.

  

    	5

    	 

    
  

9. Notice. All notices
and other communications hereunder shall be in writing and shall be deemed to have been given (i) on the date they are delivered
if delivered in person; (ii) on the date initially received if delivered by facsimile transmission followed by registered or certified
mail confirmation; (iii) on the date delivered by an overnight courier service; or (iv) on the third business day after it is mailed
by registered or certified mail, return receipt requested with postage and other fees prepaid as follows:

 

If to the Company:

 

Revolutions Medical Corporation

670 Marina Drive, 3rd Floor

Charleston, SC 29466

Attn: Rondald Wheet

Chief Executive Officer

 

If to the Warrant Holder:

 

________________________

 

________________________

 

________________________

 

10. Miscellaneous.

 

a. This Warrant shall
be binding on and inure to the benefit of the parties hereto and their respective successors and permitted assigns. This Warrant
may be amended only in writing and signed by the Company and the Warrant Holder.

 

b. Nothing in this Warrant
shall be construed to give to any person or corporation other than the Company and the Warrant Holder any legal or equitable right,
remedy or cause of action under this Warrant; this Warrant shall be for the sole and exclusive benefit of the Company and the Warrant
Holder.

 

c. This Warrant shall
be governed by, construed and enforced in accordance with the internal laws of the State of South Carolina without regard to the
principles of conflicts of law thereof.

 

d. The headings herein
are for convenience only, do not constitute a part of this Warrant and shall not be deemed to limit or affect any of the provisions
hereof.

 

e. In case any one or
more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceablilty of the
remaining terms and provisions of this Warrant shall not in any way be affected or impaired thereby and the parties will attempt
in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonably substitute therefore, and
upon so agreeing, shall incorporate such substitute provision in this Warrant.

 

    	6

    	 

    

 

f. The Warrant Holder
shall not, by virtue hereof, be entitled to any voting or other rights of a shareholder of the Company, either at law or equity,
and the rights of the Warrant Holder are limited to those expressed in this Warrant.

 

[-signature page follows-]

 

    	7

    	 

    

 

IN WITNESS WHEREOF, the
Company has caused this Warrant to be duly executed by the authorized officer as of the date first above stated.

 

 

	 	REVOLUTIONS MEDICAL CORPORATION
	 	 
	 	By: 	 
	 	 	Name: Rondald Wheet
Title: Chief Executive Officer

  

    	8

    	 

    

 

FORM OF ELECTION TO PURCHASE

 

(To be executed by the Warrant Holder to exercise the
right to purchase shares of Common Stock under the foregoing Warrant)

 

To: REVOLUTIONS MEDICAL CORPORATION

 

The undersigned, pursuant to the provisions
set forth in the attached Warrant (No.____), hereby irrevocably elects to purchase (check applicable box):

 

___ ________ shares of the Common Stock covered
by such Warrant; or

	___	the maximum number of shares of Common Stock covered by such Warrant pursuant to the cashless exercise procedure set forth therein.

 

The undersigned herewith makes payment of the
full purchase price for such shares at the price per share provided for in such Warrant, which is $___________. Such payment takes
the form of (check applicable box or boxes):

 

___ $__________ in lawful money of the United
States; and/or

	___	the cancellation of such portion of the attached Warrant as is exercisable for a total of _______ shares of Common Stock (using a Fair Market Value of $_______ per share for purposes of this calculation); and/or

 

	___	the cancellation of such number of shares of Common Stock as is necessary, in accordance with the formula set forth in Section 2 of the Warrant, to exercise this Warrant with respect to the maximum number of shares of Common Stock purchasable pursuant to the cashless exercise procedure set forth in Section 2.

 

After application of the cashless exercise
feature as described above, _____________ shares of Common Stock are required to be delivered pursuant to the instructions below.

 

The undersigned requests that the certificates
for such shares be issued in the name of, and delivered to __________________________________________, whose address is _____________________________________________________________________________.

 

 

[signature page follows]

 

    	9

    	 

    

The undersigned represents and warrants that
all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant shall be made pursuant to
registration of the Common Stock under the Securities Act of 1933, as amended (the “Securities Act”), or pursuant to
an exemption from registration under the Securities Act.

 

	
         

         

         
	 	
        Name of Warrant Holder:

         

        (Print)___________________________________

         

        (By:)____________________________________

         

        (Name:)_________________________________

         

        (Title:)__________________________________

         

        Signatures must conform in all respects to
        the name of the Warrant Holder on the face of the Warrant.

         

 

    	10FORM OF SUBSCRIPTION
AGREEMENT

 

THIS
SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of ________________, 2012, by and between Revolutions
Medical Corporation, a corporation incorporated under the laws of the State of Nevada and located at 670 Marina Drive, 3rd
Floor, Charleston, South Carolina 29292 (the “Company”), and ______________________________,
an individual located at ______________________________________________ (the “Subscriber”). 

 

WHEREAS, the Company
and Subscriber are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded
by the provisions of Section 4(2) and/or Regulation D (“Regulation D”) promulgated by the United States Securities
and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities
Act”); and

 

WHEREAS, the
parties hereto desire that, upon the terms and subject to the conditions contained herein and upon the date hereof (the
“Funding Date”), the Company shall issue to the Subscriber (1) a convertible promissory note (the
“Note”) in the principal amount of ___________________________________________ and 00/100 United States
Dollars (US$________________________________) (the “Principal Amount”), pursuant to which the Principal
Amount owed thereunder shall be convertible into such number of shares of common stock, par value $.001 per share, of the
Company (the “Common Stock”) as set forth in the Note; (2) a warrant (the “Warrant A”)
permitting the Subscriber to purchase __________ _______ shares of the Company’s Common Stock at a per share price of
Zero and 25/100 United States Dollars (US$0.25) subject to the terms and conditions therein contained; and (3) a warrant (the
“Warrant B”, and together with the Warrant A, collectively, the “Warrants”; and
together with the Note, collectively, the “Transaction Documents”) permitting the Subscriber to purchase
__________ ________ shares of the Company’s Common Stock at a per share price of Zero and 50/100 United States
Dollars (US$0.50), subject to the terms and conditions therein contained (the shares of Common Stock issuable pursuant to the
Note and the Warrants shall collectively be referred to herein as the “Shares”; the Note, the Warrants and
the Shares shall be referred to collectively herein as the “Securities”).

 

NOW, THEREFORE,
in consideration of the mutual covenants and other agreements contained in this Agreement, the Company and Subscriber hereby agree
as follows:

 

1.
Purchase and Sale. Upon the terms and subject to the conditions set forth in this Agreement and in consideration
of the Principal Amount delivered by the Subscriber to the Company on the Funding Date or shortly thereafter, the Company hereby
agrees to issue the Note and the Warrants to the Subscriber on the Funding Date or shortly thereafter. The Company agrees to issue
and deliver the Securities to the Subscriber free of all liens, pledges, mortgages, security interests, charges, restrictions,
adverse claims or other encumbrances of any kind or nature whatsoever (“Encumbrances”), and Subscriber hereby
agrees to accept the Securities free of all Encumbrances.

 

    	1

    	 

    
 

2.
Subscriber Representations and Warranties. Subscriber hereby represents and warrants to and agrees with the Company
that:

 

(a) Standing of Subscriber.
Subscriber has the legal capacity and power to enter into this Agreement.

 

(b) Authorization and
Power. Subscriber has the requisite power and authority to enter into and perform this Agreement and to advance the Principal
Amount and accept the Note and Warrants. The execution, delivery and performance of this Agreement by the Subscriber, and the consummation
by the Subscriber of the transactions contemplated hereby, have been duly authorized by all necessary action, and no further consent
or authorization of Subscriber is required. This Agreement has been duly authorized, executed and delivered by the Subscriber and
constitutes, or shall constitute, when executed and delivered, a valid and binding obligation of thr Subscriber, enforceable against
Subscriber in accordance with the terms hereof.

 

(c) Information on Subscriber.
Subscriber is, and reasonably believes he will be at the time of the conversion of the Note and exercise of the Warrants, an “accredited
investor,” as such term is defined in Regulation D promulgated by the Commission under the 1933 Act, is experienced in investments
and business matters, has made investments of a speculative nature and has purchased securities of United States publicly-owned
companies in private placements in the past and, with its representatives, has such knowledge and experience in financial, tax
and other business matters as to enable the Subscriber to utilize the information made available by the Company to evaluate the
merits and risks of, and to make an informed investment decision with respect to, the proposed purchase, which the Subscriber hereby
agrees represents a speculative investment. The Subscriber has the authority and is duly and legally qualified to purchase and
own the Securities. The Subscriber is able to bear the risk of such investment for an indefinite period and to afford a complete
loss thereof.

 

(d) Purchase of Securities.
The Subscriber will purchase the Securities for its own account for investment and not
with a view toward, or for resale in connection with, the public sale or any distribution thereof in violation of the Securities
Act or any applicable state securities law, and has no direct or indirect arrangement or understandings with any other person or
entity to distribute or regarding the distribution of such Shares;

 

(e) Compliance
with Securities Act. The Subscriber understands and agrees that the Securities have not been registered under the 1933 Act
or any applicable state securities laws by reason of their issuance in a transaction that does not require registration under the
1933 Act (based in part on the accuracy of the representations and warranties of Subscriber contained herein), and that such Securities
must be held indefinitely unless a subsequent disposition is registered under the 1933 Act or any applicable state securities laws
or is exempt from such registration.

 

    	2

    	 

    
 

(f) Share Legend.
The Shares shall bear the following or similar legend:

 

“THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAS NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, NOR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER AND REASONABLY APPROVED BY THE COMPANY), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

(g)
Note and Warrants Legend. The Note and Warrants shall bear the following or similar legend

 

“NEITHER THE ISSUANCE AND SALE OF
THE SECURITIES REPRESENTED BY THIS DOCUMENT NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER AND REASONABLY APPROVED BY
THE COMPANY), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO
RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”

 

(h)
Communication of Offer. Subscriber has a preexisting personal or business relationship with the Company or one or
more of its directors, officers, advisors or control persons, and the offer to issue the Securities
was directly communicated to Subscriber by the Company. At no time was Subscriber presented with or solicited by any leaflet, newspaper
or magazine article, radio or television advertisement, or any other form of general advertising or solicited or invited to attend
a promotional meeting otherwise than in connection and concurrently with such communicated offer;

 

(i)
No Governmental Endorsement. Subscriber understands that no United States federal or state agency or any other governmental
or state agency has passed on or made recommendations or endorsement of the Securities, or the
suitability of the investment in the Securities, nor have such authorities passed upon or endorsed
the merits of the offering of the Securities;

 

    	3

    	 

    
 

(j) Receipt of Information.
Subscriber believes it has received all the information it considers necessary or appropriate for deciding whether to invest the
Principal Amount in the Company and to accept the Securities. Subscriber further represents that through its representatives it
has had an opportunity to ask questions and receive answers from the Company regarding the terms and conditions of the offering
of the Securities and the business, properties and financial condition of the Company and to obtain additional information (to
the extent the Company possessed such information or could acquire it without unreasonable effort or expense) necessary to verify
the accuracy of any information furnished to it or to which it had access; and

 

(k) No Market Manipulation.
Subscriber has not taken, and will not take, directly or indirectly, any action designed to, or that might reasonably be expected
to, cause or result in stabilization or manipulation of the price of the Common Stock, to facilitate the sale or resale of the
Shares or affect the price at which the Shares may be issued or resold.

 

3. Company Representations
and Warranties. The Company represents and warrants to, and agrees with, Subscriber that:

 

(a) Due Incorporation.
The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the jurisdiction of its
incorporation;

 

(b)
Authority; Enforceability. The Transaction Documents have been duly authorized, executed and delivered by the Company and
are the valid and binding agreements of the Company, enforceable in accordance with their terms, except as may be limited
by bankruptcy, insolvency, moratorium or other similar laws affecting the enforcement of creditors’ rights generally, or
principles of equity. The Company has full corporate power and authority necessary to enter into and
deliver the Transaction Documents and to perform its obligations thereunder;

 

(c) Capitalization and
Additional Issuances. The Company has authorized Two Hundred Fifty Million (250,000,000) shares of Common Stock. As of November
18, 2011, there were 52,292,644 shares of the Common Stock issued and outstanding. All of the outstanding shares of the Common
Stock are, and the Shares to be issued pursuant to the Note and the Warrants will be, duly authorized and validly issued, fully
paid and non-assessable and are not (and will not be) subject to preemptive or similar rights affecting the Common Stock.

 

(d)
SEC Filings. The Company has filed with the SEC all documents required to be filed or furnished by it with the SEC
(the “Company SEC Documents”) and such Company SEC Documents when filed were true, correct and complete in all
material respects. As of their respective filing dates (or, if amended or superseded by a subsequent filing, as of the date of
the last such amendment or superseding filing prior to the date hereof), each of the Company SEC Documents complied in all material
respects with the applicable requirements of the Exchange Act, and the rules and regulations of the SEC thereunder applicable to
such Company SEC Documents and did not, at the time it was filed (or, if amended, at the time (and taking into account the content)
of such amendment), contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading.

 

    	4

    	 

    
 

(e) Consents. No
consent, approval, authorization or order of any court, governmental agency or body having jurisdiction over the Company or of
any other person is required for the execution by the Company of the Transaction Documents and compliance and performance by the
Company of its obligations hereunder and thereunder, including, without limitation, the issuance of the Securities;

 

(f) No Violation or
Conflict. Neither the issuance of the Securities nor the performance of the Company’s obligations under the Transaction
Documents will:

 

(i) violate, conflict with,
result in a breach of, or constitute a default (or an event which with the giving of notice or the lapse of time or both would
be reasonably likely to constitute a default) under (a) the charter or bylaws of the Company or (b) any decree, judgment, order
or determination applicable to the Company of any court, governmental agency or body having jurisdiction over the Company or over
the properties or assets of the Company; or

 

(ii) result in the creation
or imposition of any lien, charge or encumbrance upon the Shares except in favor of Subscriber as described herein;

 

(g) The Shares.
Upon issuance, the Shares:

 

(i) shall be free and clear
of any security interests, liens, claims or other Encumbrances, subject only to restrictions upon transfer under the Securities
Act and any applicable state securities laws;

 

(ii) shall have been duly
and validly issued, fully paid and non-assessable; and

 

(iii) will not subject the
holders thereof to personal liability by reason of being such holders;

 

(h) No General Solicitation.
Neither the Company, nor any of its affiliates, nor any person or entity acting on its or their behalf, has engaged in any form
of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with
the offer or sale of the Securities; and

 

(i) Investment Company.
The Company is not an “investment company” within the meaning of the Investment Company Act of 1940, as amended.

 

    	5

    	 

    

4. Non-Public Information.
While the Note and Warrants are held by the Subscriber, the Company covenants and agrees that neither it nor any other person acting
on its behalf will at any time provide the Subscriber with any information that the Company believes constitutes material non-public
information. Notwithstanding the above, in the event that the Company delivers to the Subscriber any notice or information, in
writing, electronically or otherwise containing material non-public information, the Company shall, within four (4) days after
any such delivery, publicly disclose such material, nonpublic information on Form 8-K, such disclosure to cure any violation of
the negative covenant contained in this Section. The Company understands and confirms that the Subscriber shall be relying on the
foregoing representations in effecting transactions in securities of the Company.

 

5. Right of First Refusal.
While the Note and Warrants are held by the Subscriber, the Subscriber shall be given not less than three (3) days prior written
notice (the “Notice”) of any proposed sale by the Company (each such proposed sale, an “Other Offering”)
of its Common Stock or other securities or equity linked debt obligations (the “Offering Securities”), except
for any proposed sale in connection with any equity line facility entered into by the Company. The Subscriber shall have the right,
during the three (3) days following receipt of the Notice, to purchase up to all of such Offering Securities in accordance
with the terms and conditions set forth in the Notice and the Other Offering documents.

 

6.
Broker’s Commission/Finder’s Fee. Each party hereto represents to the other that there are no parties
entitled to receive fees, commissions, finder’s fees, due diligence fees or similar payments in connection with the consummation
of the transactions contemplated hereby. Each party hereto agrees to indemnify the other against and hold the other harmless from
any and all liabilities to any persons claiming brokerage commissions or similar fees on account of services purported to have
been rendered on behalf of the indemnifying party in connection with this Agreement or the transactions contemplated hereby and
arising out of the indemnifying party’s actions.

 

7.
Covenants Regarding Indemnification. Each party hereto
agrees to indemnify, hold harmless, reimburse and defend the other party and the other party’s officers, directors, agents,
counsel, affiliates, members, managers, control persons, and principal shareholders, as applicable, against any claim, cost, expense,
liability, obligation, loss or damage (including reasonable legal fees) of any nature, incurred by or imposed upon the indemnified
party or any such person which results, arises out of or is based upon (i) any breach of any representation or warranty by the
indemnifying party in this Agreement or (ii) any breach or default in performance by the indemnifying party of any covenant or
undertaking to be performed by the indemnifying party.

 

8. Miscellaneous.

 

(a) Notices. All
notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and,
unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery or facsimile, addressed as set forth in the preamble paragraph hereto or to such other address as such party shall
have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall
be deemed effective (a) upon hand delivery at the address designated in the preamble paragraph hereto (if delivered on a business
day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered
other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day
following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such
mailing, whichever shall first occur.

 

    	6

    	 

    
 

(b) Entire Agreement.
This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and may be
amended only by a writing executed by both parties hereto. Neither the Company nor Subscriber has relied on any representations
not contained or referred to in this Agreement and the documents delivered herewith.

 

(c) Counterparts/Execution.
This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate counterparts,
each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument.
This Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic means with the
same force and effect as if such signature page were an original thereof.

 

(d)
Law Governing this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the
State of South Carolina without regard to principles of conflicts of laws. Any action brought by either party hereto against the
other concerning the transactions contemplated by this Agreement shall be brought only in the state courts of South Carolina or
in the federal courts located in the State of South Carolina. The parties to this Agreement hereby irrevocably waive any objection
to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or
venue or based upon forum non conveniens. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES
NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS
AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 

 

(e) Severability.
In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party
hereto hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute
good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right
to serve process in any other manner permitted by law.

 

    	7

    	 

    
 

(f) Counsel; Ambiguities.
Each party and its counsel have participated fully in the review and revision of this Agreement and the other Transaction Documents.
The parties understand and agree that any rule of construction to the effect that ambiguities are to be resolved against the drafting
party shall not apply in interpreting this Agreement or the other Transaction Documents. The language in this Agreement and the
other Transaction Documents shall be interpreted as to its fair meaning and not strictly for or against any party.

 

(g)
Captions. The captions of the various sections and paragraphs of this Agreement have been inserted only for the purposes
of convenience; such captions are not a part of this Agreement and shall not be deemed in any manner to modify, explain, enlarge
or restrict any of the provisions of this Agreement.

 

[signature page follows]

  

    	8

    	 

    

 

IN WITNESS WHEREOF, the parties has caused
this Agreement to be executed on and as of the date set forth above.

 

 

 

	 	REVOLUTIONS MEDICAL CORPORATION
	 	 
	 	By: 	 
	 	 	Name: Rondald Wheet
Title: Chief Executive Officer

 

 

	SUBSCRIBER:
	
         

        Name of Subscriber:

         

        _________________________________________

         

        Address:

         

        _________________________________________

         

        _________________________________________

         

        Fax No.: _________________________________

         

        Taxpayer ID# (if applicable): _________________

         

         

        _________________________________________

        (Signature)

         

        By: _____________________________________

         

        Dated: ______________________________, 2012

         

 

[Signature
Page to Revolutions Medical Corporation Subscription Agreement]

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]